![]() |
Volumn 1, Issue 1, 2011, Pages 1-24
|
Vaccine evolution
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
COWPOX VACCINE;
DENDRITIC CELL VACCINE;
HAEMOPHILUS INFLUENZAE VACCINE;
IMMUNOLOGICAL ADJUVANT;
INACTIVATED VACCINE;
LIVE VACCINE;
MENINGOCOCCUS VACCINE;
PNEUMOCOCCUS VACCINE;
POLIOMYELITIS VACCINE;
SMALLPOX VACCINE;
TYPHOID VACCINE;
UNCLASSIFIED DRUG;
VACCINE;
VIRUS VACCINE;
WATER;
ANTIBODY TITER;
ARTICLE;
CANCER IMMUNOTHERAPY;
CELL CULTURE;
COWPOX;
CULTURE MEDIUM;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG SAFETY;
ERADICATION THERAPY;
GENETIC ENGINEERING;
GENETIC REASSORTMENT;
GERM THEORY OF DISEASE;
HAEMOPHILUS INFECTION;
HEALTH PROGRAM;
HEALTH PROMOTION;
HISTORY OF MEDICINE;
HUMAN;
INFECTION CONTROL;
MENINGOCOCCOSIS;
NONHUMAN;
PNEUMOCOCCAL INFECTION;
POLIOMYELITIS;
PRIORITY JOURNAL;
RECOMBINANT DNA TECHNOLOGY;
RISK BENEFIT ANALYSIS;
SMALLPOX;
TYPHOID FEVER;
VACCINATION;
VACCINE PRODUCTION;
VIROGENESIS;
VIRUS GENE;
ZYGOTE;
|
EID: 83455213270
PISSN: 22107622
EISSN: None
Source Type: Journal
DOI: 10.1016/j.pervac.2011.05.001 Document Type: Article |
Times cited : (22)
|
References (8)
|